Ageing, ACE2 deficiency and bad outcome in COVID-19

被引:16
作者
Angeli, Fabio [5 ,6 ]
Reboldi, Gianpaolo [1 ,2 ]
Verdecchia, Paolo [3 ,4 ]
机构
[1] Univ Perugia, Dept Med, Perugia, Italy
[2] Univ Perugia, Ctr Ric Clin & Traslazionale CERICLET, Perugia, Italy
[3] Hosp S Maria Misericordia, Fdn Umbra Cuore & Ipertensione ONLUS, Perugia, Italy
[4] Hosp S Maria Misericordia, Div Cardiol, Perugia, Italy
[5] Univ Insubria, Dept Med & Surg, Varese, Italy
[6] IRCCS Tradate, Maugeri Care & Res Inst, Dept Med & Cardiopulm Rehabil, Tradate, Italy
关键词
D O I
10.1515/cclm-2021-0658
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:1607 / 1609
页数:3
相关论文
共 50 条
  • [21] ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery
    Lores, Enrique
    Wysocki, Jan
    Batlle, Daniel
    CLINICAL SCIENCE, 2020, 134 (21) : 2791 - 2805
  • [22] ACE2, a drug target for COVID-19 treatment?
    Liu, Yang
    Huang, Huilian
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (02) : 919 - 921
  • [23] COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit?
    Zhang, Ting
    Zhong, Sen
    Cao, Wenzhai
    PREHOSPITAL AND DISASTER MEDICINE, 2020, 35 (06) : 700 - 701
  • [24] COVID-19 susceptibility: potential of ACE2 polymorphisms
    Mayank Chaudhary
    Egyptian Journal of Medical Human Genetics, 21
  • [25] A historical perspective on ACE2 in the COVID-19 era
    Vivek Bhalla
    Catherine A. Blish
    Andrew M. South
    Journal of Human Hypertension, 2021, 35 : 935 - 939
  • [26] Impact of ACE2 on the susceptibility and vulnerability to COVID-19
    Pringle, Kirsty G.
    Philp, Lisa K.
    JOURNAL OF ENDOCRINOLOGY, 2023, 258 (03)
  • [27] COVID-19 infection: ACE2, pregnancy and preeclampsia
    Todros, Tullia
    Masturzo, Bianca
    De Francia, Silvia
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 253 : 330 - 330
  • [28] A historical perspective on ACE2 in the COVID-19 era
    Bhalla, Vivek
    Blish, Catherine A.
    South, Andrew M.
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (10) : 935 - 939
  • [29] The therapeutic potential of targeting ACE2 in COVID-19
    Elmors, R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (18) : 9744 - 9747
  • [30] Soluble ACE2 as a potential therapy for COVID-19
    Krishnamurthy, Sudarshan
    Lockey, Richard F.
    Kolliputi, Narasaiah
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (03): : C279 - C281